Canaccord raised the firm’s price target on Organigram (OGI) to C$4 from C$3 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGI:
- Organigram Secures C$65.2 Million BAT Investment to Back Sanity Group Deal
- Organigram announces C$65.2M BAT private placement investment
- Organigram to Acquire Germany’s Sanity Group in Major European Cannabis Push
- Organigram to acquire remaining shares of Sanity Group for EUR113.4M
- Organigram Delivers Strong Q1 2026 Growth and Expands U.S. Reach